GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

ECRID ECDD · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 5 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2022

Net income

−$1.7m

FY2017FY2022

Free cash flow

−$39,981

FY2017FY2022

Shareholders' equity

−$12,477

FY2017FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017
Operating income−$1.7m−$7.6m−$52,230−$26,331−$49,819−$32,250
Net income−$1.7m−$7.6m−$52,234−$26,331−$51,156−$32,250
Diluted earnings per share-0.01-0.03-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$10,019$35,632$68$74$48—
Cash and short-term investments$10,019———$5—
Total liabilities$22,496—$16——$33,000
Debt—————$33,000
Shareholders' equity−$12,477$35,632$52$74$48—
Shares outstanding289m284m231m88m60m10m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−$39,981−$8,603−$30,000−$54,739−$96−$32,250
Free cash flow−$39,981−$8,603−$30,000−$54,739−$96−$32,250

Latest quarters

By quarter end

Sept 2022Jun 2022Dec 2021Sept 2021Jun 2021Mar 2021Sept 2020Jun 2020
Operating income−$15,369−$4,293−$2,608−$87,163−$43,582−$7.6m−$8,098−$8,099
Net income−$15,369−$4,293−$2,608−$87,163−$43,582−$7.6m−$8,098−$8,099
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.03-0.00-0.00
Total assets$26,650$7,571$1.2m$1.2m—$35,632——
Cash and short-term investments$26,650$10,019$63,304$80,349————
Shareholders' equity−$32,140−$16,770$980,861$983,469$35,632$35,632—$51,829

Valuation history

At each fiscal year end

FY2022FY2021FY2020
Price to earnings-1.3-0.1-0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return500%100%-100%612%116951%124%1508%98%2922%453850%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 70-to-1 reverse split · 16 Oct 2017
  • 50-to-1 reverse split · 8 Feb 2008
  • 1.01-for-1 split · 20 Oct 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.